Analystreport

Regeneron (NASDAQ: REGN) was given a new $290.00 price target on by analysts at Barclays. They now have a "sell" rating on the stock.

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com